Teri Loxam's Insider Trades & SAST Disclosures
Teri Loxam's most recent trade in Compass Pathways Plc - ADR was a trade of 76,000 Share Option (Right to Buy) done . Disclosure was reported to the exchange on March 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Teri Loxam.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Compass Pathways Plc - ADR | Teri Loxam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 76,000 | 76,000 | - | - | Share Option (Right to Buy) | |
| Compass Pathways Plc - ADR | Teri Loxam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 25,000 | 83,250 | - | 0 | Ordinary Shares | |
| Compass Pathways Plc - ADR | Teri Loxam | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.67 per share. | 03 Mar 2025 | 4,468 | 58,250 | - | 3.7 | 16,398 | Ordinary Shares |
| Vaxcyte Inc | Teri Loxam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 6,250 | 6,250 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Teri Loxam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.70 per share. | 15 Jan 2025 | 6,250 | 13,425 | - | 22.7 | 141,875 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 83.93 per share. | 15 Jan 2025 | 1,202 | 10,726 | - | 83.9 | 100,885 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 82.89 per share. | 15 Jan 2025 | 1,136 | 11,928 | - | 82.9 | 94,168 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 85.29 per share. | 15 Jan 2025 | 1,043 | 9,683 | - | 85.3 | 88,961 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 87.38 per share. | 15 Jan 2025 | 1,013 | 7,704 | - | 87.4 | 88,513 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 86.26 per share. | 15 Jan 2025 | 966 | 8,717 | - | 86.3 | 83,324 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 88.54 per share. | 15 Jan 2025 | 529 | 7,175 | - | 88.5 | 46,836 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 81.53 per share. | 15 Jan 2025 | 215 | 13,064 | - | 81.5 | 17,530 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 80.46 per share. | 15 Jan 2025 | 146 | 13,279 | - | 80.5 | 11,747 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.70 per share. | 17 Sep 2024 | 6,250 | 13,425 | - | 22.7 | 141,875 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2024 | 6,250 | 12,500 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 116.62 per share. | 17 Sep 2024 | 4,308 | 7,431 | - | 116.6 | 502,387 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 115.32 per share. | 17 Sep 2024 | 1,445 | 11,739 | - | 115.3 | 166,634 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 117.51 per share. | 17 Sep 2024 | 256 | 7,175 | - | 117.5 | 30,083 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Sale of securities on an exchange or to another person at price $ 114.64 per share. | 17 Sep 2024 | 241 | 13,184 | - | 114.6 | 27,628 | Common Stock |
| Vaxcyte Inc | Teri Loxam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,250 | 7,250 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Teri Loxam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 1,550 | 7,175 | - | 0 | Common Stock | |
| Compass Pathways Plc - ADR | Teri Loxam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 117,643 | 117,643 | - | - | Share Option (Right to Buy) | |
| Compass Pathways Plc - ADR | Teri Loxam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 62,718 | 62,718 | - | 0 | Ordinary Shares | |
| Vaxcyte Inc | Teri Loxam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Teri Loxam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 2,500 | 5,625 | - | 0 | Common Stock | |
| Vaxcyte Inc | Teri Loxam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 18,750 | 18,750 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Teri Loxam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,125 | 3,125 | - | 0 | Common Stock | |
| Vaxcyte Inc | Teri Loxam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges